ECE2017 Guided Posters Bone & Calcium Homeostasis 2 (9 abstracts)
Methylation patterns at the novel DMR of GNAS (GNAS-AS2) in pseudohypoparathyroidism 1B (PHP1B or iPPSD3) subtypes
Patrick Hanna 1 , Anne Rochtus 2 , Harald Jueppner 3 , Deborah Mackay 4 , Bruno Francou 5 , Jérôme Bouligand 5 , Anne Mantel 5 , Elli Anagnostou 6 , Dominique Gaillard 7 & Agnès Linglart 1,
1INSERM U1169, Bicetre Paris Sud, France; 2University of Leuven, Leuven, Belgium; 3Massachusetts General Hospital and Harvard Medical School, Boston, USA; 4University of Southampton, Southampton, UK; 5APHP, Pharmacogenetics and Hormonology, Bicetre Paris Sud, France; 6Obstetrics and Gynecology, Alexandra Hospital, Athens, Greece; 7Génétique et Biologie de la Reproduction, Centre Hospitalier Universitaire, Reims, France; 8APHP, CMR Calcium-Phosphore, Bicêtre Paris Sud, France.
PHP1B -iPPSD3 per the new proposed classification- is a rare disorder characterized in most patients by proximal tubular resistance to PTH resulting in hypocalcemia, hyperphosphatemia and elevated PTH. Loss-of-methylation (LOM) at the Differentially Methylated Region (DMR) at GNAS exon A/B occurs in all PHP1B patients, but methylation changes at other DMRs within GNAS occur in some familial and most sporadic PHP1B cases. All patients with autosomal dominant PHP1B (AD-PHP1B) due to a maternal deletion that comprises the STX16 region (delSTX16+) present with LOM restricted to the GNAS-A/B DMR, while sporadic cases (sporPHP1B) present with broad GNAS methylation defects, including LOM at a novel, recently identified DMR within the GNAS locus referred to as antisense DMR2 (GNAS-AS2).
Objectives and patients: Characterize the methylation pattern at the GNAS-AS2 DMR in AD-PHP1B delSTX16+ (n=9) and delSTX16- (n=5) patients; furthermore, sporPHP1B (n=10) and healthy controls (n=10) were investigated. STX16 and GNAS deletions were excluded in the delSTX16- patients by MLPA, genomic multiplex and quantitative PCR of the GNAS and STX16 regions.
Results:
1. The mean methylation index at the GNAS-AS2-DMR was significantly higher in delSTX16- patients (32±14%) than in controls (24±6%), delSTX16+(5±2%) and sporPHP1B patients (3+1%) (P<0.0001).
2. Bisulfite-treated DNA of PHP1B patients with delSTX16- was PCR amplified across the GNAS-AS2-DMR and products were cloned into pcDNA3.1. First, we identified 2 CG-rich subdomains (SD1 and SD2) within the GNAS-AS2 DMR that are separated by 184 bp. Second, in delSTX16- patients we observed a unique pattern of methylation including an gain of methylation at SD1 and a methylation pattern at SD2 similar to that of controls, whereas both delSTX16+ and sporPHP1B patients displayed full LOM at SD1 and SD2.
Conclusion: We have further refined the GNAS-AS2-DMR and identified a subgroup of PHP1B patients with a specific pattern of methylation at the GNAS-AS2-DMR. Our findings reinforce the hypothesis that delSTX16- patients carry a defect in an element that controls the methylation both at the GNAS-A/B DMR and at the GNAS-AS2 DMR.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more